Cargando…

Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in Taiwan

BACKGROUND: Liver cirrhosis is one of the main causes of the morbidity and mortality in liver diseases. Chinese herbal medicine (CHM) has long been used for the clinical treatment of liver diseases. This study was designed to explore the usage frequency and prescription patterns of CHM for patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Fuu-Jen, Yang, Pei-Yuu, Chen, Chao-Jung, Li, Ju-Pi, Li, Te-Mao, Chiou, Jian-Shiun, Cheng, Chi-Fung, Chuang, Po-Heng, Lin, Ting-Hsu, Liao, Chiu-Chu, Huang, Shao-Mei, Ban, Bo, Liang, Wen-Miin, Lin, Ying-Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362535/ https://www.ncbi.nlm.nih.gov/pubmed/32664975 http://dx.doi.org/10.1186/s12906-020-03010-6

Ejemplares similares

Chinese Herbal Medicine Usage Reduces Overall Mortality in HIV-Infected Patients With Osteoporosis or Fractures
por: Ho, Mao-Wang, et al.
Publicado: (2021)

Effect of Chinese Herbal Medicine Therapy on Overall and Cancer Related Mortality in Patients With Advanced Nasopharyngeal Carcinoma in Taiwan
por: Wang, Chen-Yu, et al.
Publicado: (2021)

Chinese Herbal Medicine Therapy Reduces the Risks of Overall and Anemia-Related Mortalities in Patients With Aplastic Anemia: A Nationwide Retrospective Study in Taiwan
por: Chiu, Mu-Lin, et al.
Publicado: (2021)

Effects of Chinese Herbal Medicines on the Risk of Overall Mortality, Readmission, and Reoperation in Hip Fracture Patients
por: Cheng, Chi-Fung, et al.
Publicado: (2019)

Integrated Chinese Herbal Medicine Therapy Improves the Survival of Patients With Ovarian Cancer
por: Chang, Cherry Yin-Yi, et al.
Publicado: (2019)

Complementary Chinese Herbal Medicine Therapy Improves Survival in Patients With Pemphigus: A Retrospective Study From a Taiwan-Based Registry
por: Wu, Po-Yuan, et al.
Publicado: (2020)

Effect of Chinese Herbal Medicine Therapy on Risks of Overall, Diabetes-Related, and Cardiovascular Diseases-Related Mortalities in Taiwanese Patients With Hereditary Hemolytic Anemias
por: Chiu, Mu-Lin, et al.
Publicado: (2022)

Timing, Dosage, and Adherence of Antiretroviral Therapy and Risk of Osteoporosis in Patients With Human Immunodeficiency Virus Infection in Taiwan: A Nested Case-Control Study
por: Chiu, Mu-Lin, et al.
Publicado: (2021)

Your height affects your health: genetic determinants and health-related outcomes in Taiwan
por: Chiou, Jian-Shiun, et al.
Publicado: (2022)

Effects of Chinese herbal medicines on the occurrence of diabetic retinopathy in type 2 diabetes patients and protection of ARPE-19 retina cells by inhibiting oxidative stress
por: Tsai, Fuu-Jen, et al.
Publicado: (2017)

Association of combination antiretroviral therapy with risk of neurological diseases in patients with HIV/AIDS in Taiwan: a nested case-control study
por: Chou, Chen-Hsing, et al.
Publicado: (2023)

Effect of Chinese herbal medicine therapy on risks of all-cause mortality, infections, parasites, and circulatory-related mortality in HIV/AIDS patients with neurological diseases
por: Chiou, Jian-Shiun, et al.
Publicado: (2023)

Chinese Herbal Medicine Treatment Improves the Overall Survival Rate of Individuals with Hypertension among Type 2 Diabetes Patients and Modulates In Vitro Smooth Muscle Cell Contractility
por: Lin, Ying-Ju, et al.
Publicado: (2015)

Characteristics of Chinese herbal medicine usage in ischemic heart disease patients among type 2 diabetes and their protection against hydrogen peroxide-mediated apoptosis in H9C2 cardiomyoblasts
por: Tsai, Fuu-Jen, et al.
Publicado: (2017)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis
por: Chouik, Yasmina, et al.
Publicado: (2023)

Detection of bacterial DNA by in situ hybridization in patients with decompensated liver cirrhosis
por: Usui, Shingo, et al.
Publicado: (2017)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Prescribing Medications in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Deepak N.
Publicado: (2011)

Management of Coagulopathy in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Pooja D., et al.
Publicado: (2011)

Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
por: Nadelson, Jeffrey, et al.
Publicado: (2016)

Frequency of gallstones and mean BMI in decompensated cirrhosis
por: Rai, Ayesha Aslam, et al.
Publicado: (2018)

Clinical impact of microbiome in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2018)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Micronutrient Deficiencies in Patients with Decompensated Liver Cirrhosis
por: Llibre-Nieto, Gemma, et al.
Publicado: (2021)

Acute Myeloid Leukemia Masquerading as Decompensated Cirrhosis
por: Ahdi, Hardeep S, et al.
Publicado: (2022)

Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
por: Gurbuz, Berivan, et al.
Publicado: (2023)

Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
por: Crocombe, Dominic, et al.
Publicado: (2023)

Herbal Medicine Research in Taiwan*
por: Kaphle, Krishna, et al.
Publicado: (2006)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
por: Balcar, Lorenz, et al.
Publicado: (2022)

The Association Between Decompensated Liver Cirrhosis and Deep Neck Infection: Real-World Evidence
por: Tsai, Ming-Shao, et al.
Publicado: (2019)

Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis
por: Wu, JianPing, et al.
Publicado: (2019)

Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis
por: Ju, Young-Cheol, et al.
Publicado: (2018)

Spatial Usage and Circadian Rhythm for Older Adults in the Community in Taiwan
por: Wang, Chih-Liang, et al.
Publicado: (2021)

The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patients
por: Liao, Chia‐Te, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oqmqrbotols9539fsl4ordfoi6